Department of Urology
Sarah R. Amend has not added Biography.
If you are Sarah R. Amend and would like to personalize this page please email our Author Liaison for assistance.
Ecological paradigms to understand the dynamics of metastasis.
Cancer letters Oct, 2015 | Pubmed ID: 26458994
A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow.
Oncotarget Oct, 2016 | Pubmed ID: 27634877
Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis.
Molecular cancer research : MCR 04, 2017 | Pubmed ID: 28209759
Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
BMC cancer Jun, 2017 | Pubmed ID: 28651527
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance.
The Prostate Sep, 2019 | Pubmed ID: 31376205
The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer.
BJU international 07, 2020 | Pubmed ID: 32115854
Extracellular vesicle isolation from human renal cancer tissue.
Medical oncology (Northwood, London, England) Mar, 2020 | Pubmed ID: 32172294
Prospective evaluation of Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA level.
Medical oncology (Northwood, London, England) Sep, 2020 | Pubmed ID: 32920666
Analysis of the Circulating Tumor Cell Capture Ability of a Slit Filter-Based Method in Comparison to a Selection-Free Method in Multiple Cancer Types.
International journal of molecular sciences Nov, 2020 | Pubmed ID: 33261132
Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium.
Journal of extracellular vesicles 12, 2020 | Pubmed ID: 33489012
High-Throughput Simultaneous mRNA Profiling Using nCounter Technology Demonstrates That Extracellular Vesicles Contain Different mRNA Transcripts Than Their Parental Prostate Cancer Cells.
Analytical chemistry 03, 2021 | Pubmed ID: 33596381
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
Medical oncology (Northwood, London, England) Jul, 2021 | Pubmed ID: 34331598
The role of liquid biopsies in prostate cancer management.
Lab on a chip 09, 2021 | Pubmed ID: 34346466
Advancements in the identification of EV derived mRNA biomarkers for liquid biopsy of clear cell renal cell carcinomas.
Urology Nov, 2021 | Pubmed ID: 34793840
Chi-Ju Kim*,1,2,
Morgan D. Kuczler*,1,
Liang Dong1,3,
Junyoung Kim2,4,
Sarah R. Amend1,
Yoon-Kyoung Cho2,4,
Kenneth J. Pienta1
1The Brady Urological Institute, Johns Hopkins University School of Medicine,
2Department of Biomedical Engineering, School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST),
3Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine,
4Center for Soft and Living Matter, Institute for Basic Science (IBS)
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。